Make sure to sign up for an account today for exclusive coupons and free shipping on orders over $75!
Maximum quantity allowed is 999
CAS RN: 22457-89-2 | Product Number: B4711
Benfotiamine
Purity: >98.0%(T)(HPLC)
- S-Benzoylthiamine O-Monophosphate
Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
---|---|---|---|---|---|
5G |
$78.00
|
7 | 2 | 28 |
|
25G |
$195.00
|
Contact Us | Contact Us | 2 |
|
* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | B4711 |
Purity / Analysis Method | >98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__1__9H__2__3N__4O__6PS = 466.45 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Refrigerated (0-10°C) |
Condition to Avoid | Heat Sensitive |
CAS RN | 22457-89-2 |
Reaxys Registry Number | 771326 |
PubChem Substance ID | 253662524 |
Merck Index (14) | 1041 |
MDL Number | MFCD00057343 |
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Neutralization titration) | min. 98.0 % |
Melting Point | 192 °C(dec.) |
RTECS# | DH6910000 |
HS Number | 2933.59.8000 |
References
- Pharmacokinetics of thiamine derivatives, especially of benfotiamine (a review)
- D. Loew, Int. J. Clin. Pharmacol. Ther. 1996, 34, 47.
- Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats
- Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy
- Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes
- The multifaceted therapeutic potential of benfotiamine (a review)
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.